GlassScriptPhysician profile
Carla Raychelle Watson
NPI 1427307164
$1,035.97
in general payments reported to CMS, 2019-2025
16 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.96 · 2020: $23.67 · 2021: $46.46 · 2022: $195 · 2023: $175 · 2024: $432 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $153.83 | 2024 | |
| Neurelis, INC. | $122.48 | 2021-2025 | Valtoco |
| Genzyme Corporation | $120.07 | 2023-2024 | |
| Biomarin Pharmaceutical INC. | $112.90 | 2022 | |
| Ucb, INC. | $98.17 | 2022-2024 | Fintepla, Briviact |
| Corium, LLC | $81.34 | 2024 | Azstarys |
| Pyros Pharmaceuticals, INC. | $60.01 | 2024 | Vigpoder |
| Jazz Pharmaceuticals INC. | $59.07 | 2023-2025 | |
| Eisai INC. | $57.16 | 2022-2023 | |
| Livanova USA, INC. | $54.98 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Acadia Pharmaceuticals INC | $24.49 | 2024 | Daybue |
| Greenwich Biosciences, INC. | $23.67 | 2020 | |
| Sk Life Science, INC. | $20.99 | 2024 | Xcopri |
| Aquestive Therapeutics, INC. | $17.96 | 2019 | |
| Upsher-Smith Laboratories LLC | $16.25 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zogenix INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.